Bandaram Pharma Packtech

Bengaluru, India Founded: 2022 • Age: 4 yrs Listed
Pharmaceutical packaging solutions are provided by Bandaram Pharma Packtech.

About Bandaram Pharma Packtech

Bandaram Pharma Packtech is a publicly listed company based in Bengaluru (India) founded in 2022. Pharmaceutical packaging solutions are provided by Bandaram Pharma Packtech. Its Indian entity Bandaram Pharma Packtech Limited reported revenue of ₹62.94 Cr. Bandaram Pharma Packtech offers products and services including Investment Services. Its focus areas include Biopharma Outsourcing, Logistics & Supply Chain and Packaging. Its competitors include SCHOTT Poonawalla, Ideal Cures and Natural Capsules.

Company details

Bandaram Pharma Packtech was established in 2022 and is based in Bengaluru, India. Operations focus on the pharmaceutical sector, where packaging solutions are developed and supplied. Services include design, manufacturing, and distribution of packaging materials tailored for pharmaceutical products. The company serves clients within India, emphasizing compliance with industry standards for safety and efficiency in drug containment and transport.

  • Headquarters Bengaluru, India
  • Stage Public
  • Sectors
    Healthcare
  • Website bandaram.com
  • Legal Name Bandaram Pharma Packtech Limited
Key Metrics
  • Market Cap
    ₹32.94 Cr

    BANDARAM · BSE

  • Share Price
    ₹18.59

    +1.42% today

  • Revenue
    ₹62.92 Cr

    FY 2025-26 · +70.2% YoY

  • EBITDA
    ₹2.90 Cr

    Margin 4.6%

  • Net Profit
    ₹0.45 Cr

    FY 2025-26 · -54.1% YoY

  • P/E (TTM)
    132.4x

    P/B 1.2x

  • ROE
    1.4%

    ROCE 4.8%

  • Debt / Equity
    1.04

    Interest cover 78.2x

Products & Services of Bandaram Pharma Packtech

Bandaram Pharma Packtech offers a comprehensive portfolio of products and services, including Investment Services.

Investment Services
Financial Services

Managing investments in subsidiaries for long-term growth and value

Board of directors of Bandaram Pharma Packtech Limited (Bandaram Pharma Packtech)

Bandaram Pharma Packtech Limited is the primary company behind Bandaram Pharma Packtech. The board of Bandaram Pharma Packtech Limited currently have 7 directors; the longest-serving is Bhandaram Sathyavathi, appointed in 2022. 26 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Bhandaram Sathyavathi
DIN 07638353
Director07 Mar 20224 yrs 8 moBandaram Pharma Packtech Limited
Bhandaram Premsai Reddy
DIN 07170946
Director07 Mar 20224 yrs 8 moBandaram Pharma Packtech Limited
Suryaprakasa Rao Bommisetti
DIN 08089189
Director07 Mar 20224 yrs 8 moBandaram Pharma Packtech Limited
Deepak Bandaram
DIN 07074102
Managing Director07 Feb 20233 yrs 9 moBandaram Pharma Packtech Limited
Suman Mallu
DIN 10302888
Director01 Sep 20233 yrs 2 moBandaram Pharma Packtech Limited
Mounika Pammi
DIN 11111376
Director20 Jun 20251 yr 4 moBandaram Pharma Packtech Limited
Eswar Reddy Putturu
DIN 11510880
Director30 Jan 20269 moBandaram Pharma Packtech Limited

IPO & Listings of Bandaram Pharma Packtech

Bandaram Pharma Packtech is a publicly listed company on the BSE with ticker symbol BANDARAM in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date26 Aug 1994
  • Listed onBSE: 524602
  • Listed entityBandaram Pharma Packtech Limited
  • Exchange sectorHealth technology
  • ISININE875N01036
  • Share price₹19.10 (+2.96% on the day) · 2026-10-14
  • Volume (last session)276

Financials of Bandaram Pharma Packtech

Exchange-reported figures of Bandaram Pharma Packtech Limited, the listed company behind Bandaram Pharma Packtech (BSE: BANDARAM).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹62.92 Cr
+70.2% YoY
EBITDA
₹2.90 Cr
+3.2% YoY
Profit After Tax
₹0.45 Cr
-54.1% YoY
Net Worth
₹26.78 Cr
+111.7% YoY
Total Assets
₹55.31 Cr
+67.7% YoY
Total Debt
₹23.95 Cr
+39.7% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Income statement
Revenue62.9236.9634.0818.73
Revenue growth+70.2%+8.5%+82.0%-
EBITDA2.902.812.821.15
EBITDA margin+4.6%+7.6%+8.3%+6.1%
Profit before tax0.441.301.190.32
Net profit0.450.980.950.13
Net profit margin+0.7%+2.7%+2.8%+0.7%
EPS (₹)0.250.830.790.47
Balance sheet
Total assets55.3132.9827.2719.34
Net worth26.7812.6512.283.08
Total debt23.9517.1512.2014.20
Cash & bank0.720.120.040.16
Net working capital36.5625.0221.3514.27
Cash flow
Cash from operations(4.92)(4.93)(4.13)(1.10)
Cash from investing0.00(0.08)(1.58)(5.30)
Cash from financing5.535.095.594.47
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue21.4523.9526.2614.8413.728.108.4910.00
Revenue growth (YoY)+56.3%+195.7%+209.3%+48.4%+93.0%-28.8%--
Other income0.000.000.010.000.010.000.090.00
EBITDA1.161.540.821.000.450.630.540.66
EBITDA margin+5.4%+6.4%+3.1%+6.7%+3.3%+7.8%+6.4%+6.6%
Depreciation0.250.200.250.140.140.130.530.15
Interest0.480.420.460.330.250.46(0.10)0.24
Profit before tax0.430.920.120.530.070.040.200.27
Tax0.240.240.030.180.020.010.050.28
Net profit0.190.680.090.350.050.030.15(0.01)
EPS (₹)(0.12)0.110.050.110.030.020.13(0.01)
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2017-18
Income statement
Revenue10.9612.2314.8410.090.000.000.00
Revenue growth-10.4%-17.6%+47.1%----
EBITDA(1.17)0.090.160.27(0.01)(0.01)(1.12)
EBITDA margin-10.7%+0.7%+1.1%+2.7%---
Profit before tax(1.16)0.170.170.27(0.01)(0.03)(1.16)
Net profit(1.16)0.120.130.20(0.01)(0.03)(1.16)
Net profit margin-10.6%+1.0%+0.9%+2.0%---
EPS (₹)(0.64)0.120.110.68(0.03)(0.14)0.00
Balance sheet
Total assets27.4015.5912.227.482.990.100.39
Net worth22.8812.1012.203.072.99(2.32)(1.78)
Total debt4.513.490.024.410.001.451.20
Cash & bank0.260.020.040.092.080.000.00
Net working capital5.506.498.304.952.99(0.39)(0.18)
Cash flow
Cash from operations1.21(3.25)(3.26)(3.87)2.920.00(0.98)
Cash from investing(2.00)0.00(1.40)(2.53)(1.55)0.000.42
Cash from financing1.033.234.614.400.720.000.00
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue2.372.998.201.680.330.763.712.63
Revenue growth (YoY)+618.2%+293.4%+121.0%-36.1%-89.6%-72.1%--
Other income0.000.000.000.000.010.000.090.00
Total expenses2.783.348.531.890.681.033.752.58
EBITDA(0.41)(0.35)(0.33)(0.21)(0.35)(0.27)(0.04)0.05
EBITDA margin-17.3%-11.7%-4.0%-12.5%-106.1%-35.5%-1.1%+1.9%
Depreciation0.000.000.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.00
Profit before tax(0.41)(0.35)(0.33)(0.21)(0.34)(0.27)0.050.05
Tax0.000.000.000.000.000.000.010.03

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 18 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue21.4523.9526.2614.8413.728.108.4910.00
Revenue growth (YoY)+56.3%+195.7%+209.3%+48.4%+93.0%-28.8%--
Other income0.000.000.010.000.010.000.090.00
EBITDA1.161.540.821.000.450.630.540.66
EBITDA margin+5.4%+6.4%+3.1%+6.7%+3.3%+7.8%+6.4%+6.6%
Depreciation0.250.200.250.140.140.130.530.15
Interest0.480.420.460.330.250.46(0.10)0.24
Profit before tax0.430.920.120.530.070.040.200.27
Tax0.240.240.030.180.020.010.050.28
Net profit0.190.680.090.350.050.030.15(0.01)
EPS (₹)(0.12)0.110.050.110.030.020.13(0.01)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Revenue62.9236.9634.0818.73
Revenue growth+70.2%+8.5%+82.0%-
Other income0.020.090.030.19
Total expenses60.0234.1531.2617.58
Employee cost0.002.962.330.64
EBITDA2.902.812.821.15
EBITDA margin+4.6%+7.6%+8.3%+6.1%
Depreciation0.970.610.730.59
Interest1.510.990.930.43
Profit before tax0.441.301.190.32
Tax(0.01)0.320.240.07
Net profit0.450.980.950.13
Net profit margin+0.7%+2.7%+2.8%+0.7%
EPS (₹)0.250.830.790.47
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Equity & liabilities
Share capital17.9712.0012.003.00
Reserves & surplus8.810.650.280.08
Shareholders' funds (net worth)26.7812.6512.283.08
Minority interest4.583.172.792.05
Secured loans14.9210.521.781.97
Unsecured loans9.036.6310.4212.23
Total debt23.9517.1512.2014.20
Total liabilities55.3132.9827.2719.34
Assets
Gross block15.223.955.915.03
Net block15.223.954.485.03
Capital work in progress0.000.000.000.00
Investments0.001.401.400.00
Inventories12.948.516.472.71
Sundry debtors31.3518.7614.526.62
Cash & bank balances0.720.120.040.16
Loans & advances11.983.505.035.57
Total current assets56.9930.8926.0615.06
Total current liabilities20.435.874.710.79
Net working capital36.5625.0221.3514.27
Total assets55.3132.9827.2719.34
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Opening cash0.120.040.162.09
Net cash from operating activities(4.92)(4.93)(4.13)(1.10)
Net cash from investing activities0.00(0.08)(1.58)(5.30)
Net cash from financing activities5.535.095.594.47
Net change in cash0.600.08(0.11)(1.93)
Closing cash0.720.120.040.16
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Growth
Sales growth+70.2%+8.5%+82.0%-
EBITDA growth+3.2%-0.4%+145.2%-
PBT growth-66.2%+9.2%+271.9%+9997.0%
Net income growth-54.1%+3.2%+630.8%-
Revenue CAGR (3Y)+49.8%---
EBITDA CAGR (3Y)+36.1%---
Profitability & leverage
Net income margin+0.5%+2.7%+2.8%+1.3%
Return on capital employed+4.8%+8.5%+10.2%+4.4%
Return on net worth+1.4%+7.9%+12.4%+8.4%
Debt / equity1.041.181.724.61
Long-term debt / equity0.480.550.802.48
Interest cover78.2445.0044.5076.79
Efficiency & per share
Fixed asset turnover6.567.506.233.72
Inventory turnover5.874.937.426.91
Debtors turnover2.512.223.222.83
EPS (₹)0.160.830.790.47
Dividend per share (₹)0.000.100.100.10
Book value per share (₹)14.9010.5410.2310.28
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue2.372.998.201.680.330.763.712.63
Revenue growth (YoY)+618.2%+293.4%+121.0%-36.1%-89.6%-72.1%--
Other income0.000.000.000.000.010.000.090.00
Total expenses2.783.348.531.890.681.033.752.58
EBITDA(0.41)(0.35)(0.33)(0.21)(0.35)(0.27)(0.04)0.05
EBITDA margin-17.3%-11.7%-4.0%-12.5%-106.1%-35.5%-1.1%+1.9%
Depreciation0.000.000.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.00
Profit before tax(0.41)(0.35)(0.33)(0.21)(0.34)(0.27)0.050.05
Tax0.000.000.000.000.000.000.010.03
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2017-18
Revenue10.9612.2314.8410.090.000.000.00
Revenue growth-10.4%-17.6%+47.1%----
Other income0.010.090.030.000.000.000.00
Total expenses12.1312.1414.689.820.010.011.12
Employee cost0.001.101.140.080.000.000.37
EBITDA(1.17)0.090.160.27(0.01)(0.01)(1.12)
EBITDA margin-10.7%+0.7%+1.1%+2.7%---
Depreciation0.000.010.020.000.000.020.03
Interest0.000.000.000.000.000.000.01
Profit before tax(1.16)0.170.170.27(0.01)(0.03)(1.16)
Tax0.000.050.040.070.000.000.00
Net profit(1.16)0.120.130.20(0.01)(0.03)(1.16)
Net profit margin-10.6%+1.0%+0.9%+2.0%---
EPS (₹)(0.64)0.120.110.68(0.03)(0.14)0.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2017-18
Equity & liabilities
Share capital17.9712.0012.003.003.002.282.28
Reserves & surplus4.910.100.200.07(0.01)(4.60)(4.06)
Shareholders' funds (net worth)22.8812.1012.203.072.99(2.32)(1.78)
Secured loans0.000.000.000.000.000.000.00
Unsecured loans4.513.490.024.410.001.451.20
Total debt4.513.490.024.410.001.451.20
Total liabilities27.4015.5912.227.482.990.100.39
Assets
Gross block0.030.030.030.030.000.110.21
Net block0.010.010.010.030.000.110.18
Capital work in progress0.000.000.000.000.000.000.00
Investments17.853.913.912.510.000.000.00
Inventories2.081.642.160.550.000.000.00
Sundry debtors10.676.622.402.690.000.000.00
Cash & bank balances0.260.020.040.092.080.000.00
Loans & advances1.701.844.832.410.920.770.77
Total current assets14.7110.129.435.743.000.770.77
Total current liabilities9.213.631.130.790.011.160.95
Net working capital5.506.498.304.952.99(0.39)(0.18)
Total assets27.4015.5912.227.482.990.100.39
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2017-18
Opening cash0.020.040.092.080.000.000.57
Net cash from operating activities1.21(3.25)(3.26)(3.87)2.920.00(0.98)
Net cash from investing activities(2.00)0.00(1.40)(2.53)(1.55)0.000.42
Net cash from financing activities1.033.234.614.400.720.000.00
Net change in cash0.24(0.02)(0.04)(2.00)2.080.00(0.56)
Closing cash0.260.020.040.092.080.000.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2017-18
Growth
Sales growth-10.4%-17.6%+47.1%----
EBITDA growth-1400.0%-43.8%-40.7%+2800.0%0.0%--
PBT growth-0.0%-37.0%+9998.0%+66.7%+97.4%-6.4%
Net income growth-1066.7%-7.7%-35.0%+2100.0%+66.7%--
Revenue CAGR (3Y)+2.8%------
EBITDA CAGR (3Y)-----79.1%-41.5%+382.0%
Profitability & leverage
Net income margin-10.6%+1.0%+0.9%+2.0%---
Return on capital employed0.0%+1.4%+1.7%+5.2%0.0%0.0%0.0%
Return on net worth0.0%+1.2%+1.7%+6.6%0.0%0.0%0.0%
Debt / equity0.230.140.290.732.170.000.00
Long-term debt / equity0.230.140.290.732.170.000.00
Interest cover0.000.000.000.000.000.00-0.87
Efficiency & per share
Fixed asset turnover365.33407.67494.67672.670.000.000.00
Inventory turnover5.896.4410.9536.690.000.000.00
Debtors turnover1.272.715.837.500.000.000.00
EPS (₹)(0.65)0.120.110.68(0.03)(0.14)0.00
Dividend per share (₹)0.000.100.100.100.000.000.00
Book value per share (₹)12.7310.0910.1710.259.97(10.18)(7.82)

Competitors of Bandaram Pharma Packtech

Bandaram Pharma Packtech has 3 listed competitors in our database. They include SCHOTT Poonawalla, Ideal Cures and Natural Capsules.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
schott-poonawalla.com1990Mumbai, India1,297
Packaging solutions for pharmaceutical and biotech industries are provided.
idealcures.com1999Mumbai, India
Manufacturer of pharmaceutical excipients and coatings systems for solid oral dosage forms
naturalcapsules.com1993Bengaluru, India99
Manufacturing and supply chain services for biopharma sector are provided.
Premium access

Detailed competitors of Bandaram Pharma Packtech

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Bandaram Pharma Packtech

The website of Bandaram Pharma Packtech (bandaram.com) receives about 1.4K visits a month.

  • Monthly visits
    1.4K

    ▼ 14.2% vs previous month

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Bandaram Pharma Packtech (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bandaram Pharma Packtech

Premium access

Complete news archive for Bandaram Pharma Packtech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bandaram Pharma Packtech

Bandaram Pharma Packtech was founded in 2022.

Bandaram Pharma Packtech is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

The primary company behind Bandaram Pharma Packtech, Bandaram Pharma Packtech Limited, reported revenue of ₹62.94 Cr for FY 2026, up 70% year on year.

Bandaram Pharma Packtech was established in 2022 and is based in Bengaluru, India. Operations focus on the pharmaceutical sector, where packaging solutions are developed and supplied. Services include design, manufacturing, and distribution of packaging materials tailored for pharmaceutical products. The company serves clients within India, emphasizing compliance with industry standards for safety and efficiency in drug containment and transport.

Bandaram Pharma Packtech's top competitors include Natural Capsules, SCHOTT Poonawalla and Ideal Cures.

Bandaram Pharma Packtech offers Investment Services.

Yes, Bandaram Pharma Packtech is publicly traded on BSE under the ticker symbol BANDARAM.

Bandaram Pharma Packtech operates through Bandaram Pharma Packtech Limited.

The legal entities of Bandaram Pharma Packtech currently have 9 directors, including Bhandaram Sathyavathi, Bhandaram Premsai Reddy, Suryaprakasa Rao Bommisetti and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available